Luke Sergott

Stock Analyst at Barclays

(2.04)
# 2,850
Out of 4,851 analysts
278
Total ratings
38.33%
Success rate
-6.1%
Average return

Stocks Rated by Luke Sergott

Fortrea Holdings
May 13, 2025
Maintains: Underweight
Price Target: $6$5
Current: $5.00
Upside: +0.10%
Natera
May 9, 2025
Maintains: Overweight
Price Target: $160$190
Current: $166.62
Upside: +14.03%
Certara
May 8, 2025
Upgrades: Overweight
Price Target: $11$14
Current: $11.98
Upside: +16.86%
Charles River Laboratories International
May 8, 2025
Maintains: Equal-Weight
Price Target: $145$155
Current: $143.90
Upside: +7.71%
Bruker
May 8, 2025
Maintains: Overweight
Price Target: $50$46
Current: $38.36
Upside: +19.92%
IQVIA Holdings
May 7, 2025
Maintains: Equal-Weight
Price Target: $170$165
Current: $148.23
Upside: +11.31%
ICON Public Limited Company
May 2, 2025
Maintains: Equal-Weight
Price Target: $165$155
Current: $139.36
Upside: +11.23%
Exact Sciences
May 2, 2025
Maintains: Overweight
Price Target: $55$75
Current: $55.49
Upside: +35.16%
Guardant Health
May 1, 2025
Maintains: Overweight
Price Target: $55$60
Current: $46.93
Upside: +27.85%
Avantor
Apr 28, 2025
Maintains: Overweight
Price Target: $18$15
Current: $13.57
Upside: +10.54%
Maintains: Overweight
Price Target: $205$215
Current: $194.84
Upside: +10.35%
Maintains: Equal-Weight
Price Target: $400$350
Current: $353.77
Upside: -1.07%
Maintains: Overweight
Price Target: $58$45
Current: $30.57
Upside: +47.20%
Maintains: Equal-Weight
Price Target: $620$475
Current: $405.45
Upside: +17.15%
Maintains: Overweight
Price Target: $16$12
Current: $12.47
Upside: -3.77%
Maintains: Overweight
Price Target: $140$110
Current: $92.76
Upside: +18.59%
Maintains: Underweight
Price Target: $100$77
Current: $83.51
Upside: -7.80%
Maintains: Equal-Weight
Price Target: $138$115
Current: $114.47
Upside: +0.46%
Maintains: Overweight
Price Target: $15$12
Current: $9.38
Upside: +27.93%
Maintains: Equal-Weight
Price Target: $3$2
Current: $1.03
Upside: +94.17%